期刊
DERMATOLOGY
卷 207, 期 1, 页码 116-118出版社
KARGER
DOI: 10.1159/000070962
关键词
cutaneous; T-cell lymphoma; mycosis fungoides; immunotherapy; alpha-interferon; imiquimod
类别
Imiquimod is a topical immune response modifier that binds to Toll-like receptors 7 and 8 and induces a-interferon. We locally applied imiquimod 5% cream (Aldara((R))) daily for 2 weeks on a PUVA- and retinoid-resistant plaque on the face of a patient with mycosis fungoides. The diagnosis was based on clinical appearance, histology and molecular studies. Most of the disease manifestations showed a clear remission during PUVA therapy combined with low-dose retinoids. However, the plaque on the face was PUVA resistant. Local imiquimod treatment resulted in the complete clearance of the plaque. The patient has now been in complete remission for 12 months. Copyright (C) 2003 S. Karger AG, Basel.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据